Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Coutte

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Case Reports in Oncology|September 5, 2020
Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 CasesAline Houessinon, Aurélie Moreira, Jérèmie Bettoni, et al.
Cancers|May 28, 2022
Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant StrategiesYuedan Zhou, Elie Rassy, Alexandre Coutte, et al.
Case Reports in Oncology|November 10, 2012
Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at DiagnosisCelina Bihan, Sylvain Foscolo, Mathieu Boone, et al.
Frontiers in Oral Health|August 4, 2022
Evaluation of Proton MR Spectroscopy for the Study of the Tongue Tissue in Healthy Subjects and Patients With Tongue Squamous Cell Carcinoma: Preliminary FindingsSalem Boussida, Yvener François, Adrien Heintz, et al.
BMC Cancer|October 12, 2018
Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastomaLea Loriguet, Mony Chenda Morisse, Julie Dremaux, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 30, 2025
Extra- and intracranial schwannomas treated with fractionated stereotactic irradiation: Results of a retrospective, multicentric studyCaroline Beaudelot, Virginie Delgrange, Alexandre Coutte, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 24, 2025
Patterns of relapse after postoperative radiotherapy in patients with oral cavity cancer and a flapAlice Blache, Justine Lequesne, François Christy, et al.
Journal of Cancer|June 23, 2017
Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological ImpairmentIlan Darmon, Mony Chenda Morisse, Alexandre Coutte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trialJérôme Doyen, Anne Dompmartin, Coralie Cruzel, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for GlioblastomaNelly Etienne-Selloum, Julien Prades, Diana Bello-Roufai, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Case Reports in Oncology|September 5, 2020
Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 CasesAline Houessinon, Aurélie Moreira, Jérèmie Bettoni, et al.
Cancers|May 28, 2022
Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant StrategiesYuedan Zhou, Elie Rassy, Alexandre Coutte, et al.
Case Reports in Oncology|November 10, 2012
Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at DiagnosisCelina Bihan, Sylvain Foscolo, Mathieu Boone, et al.
Frontiers in Oral Health|August 4, 2022
Evaluation of Proton MR Spectroscopy for the Study of the Tongue Tissue in Healthy Subjects and Patients With Tongue Squamous Cell Carcinoma: Preliminary FindingsSalem Boussida, Yvener François, Adrien Heintz, et al.
BMC Cancer|October 12, 2018
Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastomaLea Loriguet, Mony Chenda Morisse, Julie Dremaux, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 30, 2025
Extra- and intracranial schwannomas treated with fractionated stereotactic irradiation: Results of a retrospective, multicentric studyCaroline Beaudelot, Virginie Delgrange, Alexandre Coutte, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 24, 2025
Patterns of relapse after postoperative radiotherapy in patients with oral cavity cancer and a flapAlice Blache, Justine Lequesne, François Christy, et al.
Journal of Cancer|June 23, 2017
Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological ImpairmentIlan Darmon, Mony Chenda Morisse, Alexandre Coutte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trialJérôme Doyen, Anne Dompmartin, Coralie Cruzel, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for GlioblastomaNelly Etienne-Selloum, Julien Prades, Diana Bello-Roufai, et al.
Pageof 4